Back to search

France· FR:61798869

FINCREZO 2,275 mg/mL, solution pour pulvérisation cutanée

A medicinal product containing finastéride, registered in France by LABORATOIRES BAILLEUL (LUXEMBOURG).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFINCREZO 2,275 mg/mL, solution pour p…ATC—REGISTER NO.FR:61798869PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FINASTÉRIDE
Manufacturer
LABORATOIRES BAILLEUL (LUXEMBOURG)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930292969
    1 flacon polypropylène de 18 mL (180 pulvérisations) avec une pompe munie d’un pulvérisateur en polypropylène et un applicateur (polypropylène)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Finastéride in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All finastéride products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Androfin, Finasterid +pharma
  • Belgium · Finasteride Eg, Finasteride Teva
  • Bulgaria · Пенестер, Финастерид Neo Balkanika Eood
  • Cyprus · Andropecia, Finasterid Aurobindo
  • Czechia · Androfin, Finanorm
  • Germany · Capila, Finahair
  • Denmark · Finasterid Amarox, Finasterid Aurobindo
  • Estonia · Finasteride Accord, Finasteride Teva
  • Spain · Alocare, Finasterida Almus
  • Finland · Finasterid Orion, Finasterid Ratiopharm
  • United Kingdom (Northern Ireland) · Finasteride, Finasteride 5 Mg
  • Greece · Alsteride, Andropecia
  • Croatia · Finasterid Genericon, Finasterid Pharmas
  • Hungary · Finanorm, Finasterid Teva
  • Ireland · Finasteride Accord Healthcare Ireland, Finasteride Careforsons Ireland
  • Iceland · Finasterid Stada, Finasterida Medical Valley
  • Italy · Asterid, Carefinast
  • Lithuania · Finasteride Accord, Finasteride Teva
  • Luxembourg · Finasteride Bailleul, Finasteride Eg
  • Latvia · Finasteride Accord, Finasteride Teva
  • Malta · Finasteride Ascend, Finasteride Aurobindo
  • Netherlands · Finasteride Accord, Finasteride Amarox
  • Norway · Finasterid Actavis, Proscar
  • Poland · Adaster, Androstatin
  • Portugal · Finasterida Alter, Finasterida Amarox
  • Romania · Finasterida Arena, Finasteridă Sanexcel
  • Sweden · Finaset, Finasterid Actavis
  • Slovenia · Finpros, Propecia
  • Slovakia · Androfin, Finamed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fde709ad-c2b8-4442-a1bb-3a02a4bb12bb
GET /v1/drugs/fde709ad-c2b8-4442-a1bb-3a02a4bb12bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61798869",
  "date_amm": "2024-03-28",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "FINASTÉRIDE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour pulvérisation",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about finastéride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.